Patent · US Active

Compositions comprising bowman-birk protease inhibitors and variants thereof

US7696173B2 · kind B2 · utility

18Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2008
Grant dateApr 13, 2010
Priority date
Expiry dateJul 14, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.